TEDA Administrative Commission and Tianjin KingYork Group signed an investment cooperation protocol recently at TEDA Service Center.

According to the protocol, KingYork will spend 360 million yuan on the reconstruction of its five companies, namely Tianjin KingYork Amino Acid Co., Ltd., Tianjin Tian'an Pharmaceuticals Co., Ltd., Tianjin Tianyao Pharmaceuticals Co., Ltd., Tianjin Grandsberg Pharmaceutical Co., Ltd., and Tianjin Winning Health Products Co., Ltd. Plants and facilities will be rebuilt on the original site in TEDA East Zone in the next three years. A 100,000-m3 production, logistics and storage base of freeze-dried powder, complex preparation, large volume parenteral, and low volume injection will be completed. It is expected to generate 6 billion yuan of sales revenue annually.

As one of the 14 big companies supported by Tianjin, Tianjin KingYork Group is a pharmaceutical manufacturer of over 350 products, highlighted by cortical hormone API and preparation. It is Asia's largest manufacture of cortical hormone API and preparation.